SA
PBLS logo
Parabilis Medicines, Inc.(PBLS)
Closing price · checked 4:15 PM ETAbout this dataData status
$27.63▼-0.84 (-2.97%)
After Hours:$27.63+0.00 (+0.00%)· 4:15 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 29.1 · elevated volatility

Overview →

Parabilis Medicines, Inc. (PBLS)

R&D Expenses

$152.85M

TTM · Period ending: · USD

PBLS logo

PBLS R&D Expenses

Latest reported$152.85M
PBLS R&D Expenses ($100.83M → $152.85M)
High-resolution chart · PNG

What is r&d expenses?

Research and development spending.

PBLS r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Parabilis Medicines, Inc. R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
125,583,000
100,829,000

Frequently asked questions: PBLS r&d expenses

What is Parabilis Medicines, Inc. (PBLS)'s current r&d expenses?

Parabilis Medicines, Inc. (PBLS)'s latest reported r&d expenses (TTM) is $152.85M as of Sep 30, 2026. Research and development spending.

How much historical r&d expenses data is available for PBLS?

Stock Alarm Pro provides 2 dated annual fiscal periods observations for Parabilis Medicines, Inc. (PBLS)'s r&d expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare PBLS's r&d expenses to peers or set an alert?

You can open PBLS's r&d expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on PBLS delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.